Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
CNBC
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
Chinese biopharma stocks rose on Monday after a report that the U. S. may continue to allow most drug licensing deals with Chinese firms.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC